Shares of Biogen were on track to add more than $10 billion to its market cap and erase all of its losses this year, as a surprise trial success of the experimental Alzheimer's drug it developed with Eisai https://t.co/RUtGuho0Al $BIIB pic.twitter.com/mW7wrLStQS— Reuters (@Reuters) September 28, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


